BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Saba Capital Management, L.P. Acquires 83,360 Shares

BlackRock Health Sciences Term Trust (NYSE:BMEZGet Free Report) major shareholder Saba Capital Management, L.P. bought 83,360 shares of the stock in a transaction dated Monday, February 12th. The stock was bought at an average price of 16.08 per share, for a total transaction of 1,340,428.80. Following the purchase, the insider now directly owns 19,148,163 shares of the company’s stock, valued at 307,902,461.04. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

  • On Friday, February 9th, Saba Capital Management, L.P. bought 122,094 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 15.97 per share, for a total transaction of 1,949,841.18.
  • On Wednesday, February 7th, Saba Capital Management, L.P. bought 100,354 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 15.81 per share, for a total transaction of 1,586,596.74.
  • On Monday, February 5th, Saba Capital Management, L.P. purchased 93,967 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 15.56 per share, for a total transaction of 1,462,126.52.
  • On Friday, February 2nd, Saba Capital Management, L.P. purchased 53,462 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 15.60 per share, for a total transaction of 834,007.20.
  • On Wednesday, January 31st, Saba Capital Management, L.P. purchased 134,564 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 15.50 per share, for a total transaction of 2,085,742.00.
  • On Monday, January 29th, Saba Capital Management, L.P. purchased 264,206 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 15.41 per share, for a total transaction of 4,071,414.46.
  • On Friday, January 26th, Saba Capital Management, L.P. bought 347,814 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average price of 15.26 per share, for a total transaction of 5,307,641.64.
  • On Wednesday, January 24th, Saba Capital Management, L.P. bought 113,312 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average price of 15.13 per share, for a total transaction of 1,714,410.56.
  • On Monday, January 22nd, Saba Capital Management, L.P. bought 54,477 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average price of 15.06 per share, for a total transaction of 820,423.62.
  • On Thursday, January 18th, Saba Capital Management, L.P. bought 41,792 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average price of 14.89 per share, for a total transaction of 622,282.88.

BlackRock Health Sciences Term Trust Stock Performance

NYSE BMEZ opened at 16.11 on Tuesday. BlackRock Health Sciences Term Trust has a 1-year low of 12.93 and a 1-year high of 16.95. The stock’s 50 day simple moving average is 14.96 and its 200-day simple moving average is 14.69.

BlackRock Health Sciences Term Trust Cuts Dividend

The business also recently declared a monthly dividend, which will be paid on Thursday, February 29th. Investors of record on Thursday, February 15th will be issued a $0.09 dividend. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $1.08 annualized dividend and a dividend yield of 6.70%.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Several hedge funds and other institutional investors have recently made changes to their positions in BMEZ. Saba Capital Management L.P. increased its holdings in shares of BlackRock Health Sciences Term Trust by 28.0% in the third quarter. Saba Capital Management L.P. now owns 8,347,664 shares of the company’s stock valued at $120,290,000 after purchasing an additional 1,827,094 shares during the last quarter. Lazard Asset Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 344.8% in the third quarter. Lazard Asset Management LLC now owns 642,545 shares of the company’s stock valued at $9,259,000 after purchasing an additional 498,079 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust in the third quarter valued at approximately $3,827,000. Wolverine Asset Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 260.3% in the fourth quarter. Wolverine Asset Management LLC now owns 274,318 shares of the company’s stock valued at $4,019,000 after purchasing an additional 198,177 shares during the last quarter. Finally, Prevail Innovative Wealth Advisors LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust in the second quarter valued at approximately $3,080,000.

BlackRock Health Sciences Term Trust Company Profile

(Get Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

See Also

Insider Buying and Selling by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.